 |
Protirelin |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of infant respiratory distress syndrome associated with prematurity |
| USA Market Approval | USA |
| USA Designation Date | 1993-08-24 00:00:00 |
| Sponsor | UCB Pharma, Inc.;1950 Lake Park Drive;Smyrna, Georgia, 30080 |
